People with diabetes could soon take a pill of insulin-loaded nanoparticles instead of having to give themselves painful injections, Indian researchers say. "We have already developed the capsule form ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...
Data were obtained through an Internet survey of U.S. adults self-identified as taking insulin to treat type 1 or type 2 diabetes; the survey was conducted 13 June to 7 July 2008 by Harris Interactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results